Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer
Conditions: Rectal Neoplasms Malignant; Rectum Carcinoma; Rectal Cancer Interventions: Drug: Capecitabine; Drug: Oxaliplatin; Radiation: Radiotherapy; Procedure: Rectal cancer surgery Sponsor: Blokhin's Russian Cancer Research Center Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Eloxatin | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Radiation Therapy | Neoadjuvant Therapy | Rectal Cancers | Research | Xeloda